Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 - Proteinase Inhibitor)
Clinical trial NCT00396006 · COMPLETED
Trial details
- NCT number
- NCT00396006
- Sponsor
- Baxalta now part of Shire
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-27
- Primary completion
- 2007-12-14
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.